AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16284584
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release morphine (SRM)
Trial: 7716196
Drug: Tyrosine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyrosine (100 mg/kg of body weight)
Trial: 1097203
Drug: Oral terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbutaline (5 mg)
Trial: 25385408
Drug: Group fitness
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group fitness class for pregnant women, 60 min class with 40 min endurance training and 20 min strength training, performed at least twice per week for a minimum of 12 weeks
Trial: 22136094
Drug: ER d‐MPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ER d‐MPH (10, 20, 25‐30 mg)
Trial: 14518664
Drug: Ticlopidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine plus aspirin (100 mg daily plus 81 mg daily)
Trial: 14518664
Drug: Ticlopidine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine alone (200 mg daily)
Trial: 1488568
Drug: Fenoterol/ipratropium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol/ipratropium bromide combination (Berodual) by metered dose inhaler (MDI)
Trial: 27183154
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (0.08 mg/kg)
Trial: 30219062
Drug: High zinc
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High zinc biofortified wheat flour (HZn, 30 ppm zinc daily)
Trial: 27454662
Drug: PLACEBO group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLACEBO group received placebo pills
Trial: 1394916
Drug: oxantel pyrantel
RxNorm normalized name: oxantel
DrugBank: Oxantel (DB13670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxantel pyrantel pamoate composite (pyrantel pamoate 150 mg and oxantel pamoate 150 mg bid x 2d)
Trial: 1394916
Drug: pyrantel pamoate
RxNorm normalized name: Pyrantel Pamoate
DrugBank: Pyrantel (DB11156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pyrantel pamoate composite (base 10 mg/kg, single dose)
Trial: 1394916
Drug: albendazole (400mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albendazole (400mg, single dose)
Trial: 3966851
Drug: Individual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual treatment groups with negative affective style (AS)
Trial: 3966851
Drug: Home-based family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based family treatment groups with negative affective style (AS)
Trial: 29039979
Drug: HLD200 (54
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HLD200 (54 mg)
Trial: 29453687
Drug: Clopidogrel 300
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300 mg
Trial: 9124670
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 ml (10 mg)
Trial: 9124670
Drug: Intralipid 1
RxNorm normalized name: Intralipid 100 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid 1 ml (control group)
Trial: 30264073
Drug: Tea or
RxNorm normalized name: Acai, Chromium 100mcg, Ginseng, Green Tea Oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea or cocoa flavanols (exact dosage and duration not specified)
Trial: 26721220
Drug: Citron syrup
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citron syrup (15 ml, three times daily for 4 weeks)
Trial: 26721220
Drug: Propranolol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (20 mg tablet, three times daily for 4 weeks)
Trial: 10333914
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin injected at -30 min before meal
Trial: 10333914
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin injected at -15 min before meal
Trial: 10333914
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin injected at 0 min (at meal)
Trial: 7503007
Drug: Spironolactone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50 to 100 mg/day, titrated to blood pressure and plasma potassium)
Trial: 28857658
Drug: Minocycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline (100 mg once daily, increased to 200 mg after 2 weeks)
Trial: 23415635
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine 60 μg
Trial: 23415635
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine 300 μg
Trial: 19738091
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (4 mug/kg/min)
Trial: 19738091
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no dopamine treatment)
Trial: 7519132
Drug: Aprotinin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (2 x 10(6) KIU bolus followed by 0.5 x 10(6) KIU/h continuous infusion)
Trial: 21771973
Drug: Atorvastatin, 10
RxNorm normalized name: Amlodipine Besylate-Atorvastatin, 10 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 10 mg daily
Trial: 18957811
Drug: Controlled-release nifedipine
RxNorm normalized name: nifedipine Extended Release Oral Tablet [Afeditab CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release nifedipine (nifedipine CR) plus valsartan
Trial: 6535843
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment in the program
Trial: 3467975
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg
Trial: 31625480
Drug: 2‐iminobiotin (2‐IB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐iminobiotin (2‐IB) 0.6 mg/kg, infused over periods between 15 min and 4 h, and repeated doses escalating from 0.6 mg/kg to 12 mg/kg every 4 h for 6 administrations.
Trial: 31625480
Drug: Repeated iv
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated iv dosing of 2‐IB in an acute peripheral hypoxic ischemia model.
Trial: 30125688
Drug: Daily medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily medication group (PrEP)
Trial: 20533546
Drug: Canakinumab (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canakinumab (all doses)
Trial: 15877288
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg/d) for 6 months
Trial: 8859934
Drug: Mibefradil 50
RxNorm normalized name: mibefradil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil 50 or 100 mg/day
Trial: 6723209
Drug: Ethanol (BP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (BP; 0.5 g/kg body weight) at 21 degrees C
Trial: 6723209
Drug: Ethanol (BP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (BP; 0.5 g/kg body weight) at 30 degrees C
Trial: 6723209
Drug: Ethanol (BP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (BP; 1.0 g/kg body weight) at 21 degrees C
Trial: 22588407
Drug: Periarticular injection
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Periarticular injection (PAI)
Trial: 21911616
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice (0.75 L, 9.3 mmol nitrate; H-BR)
Trial: 19234816
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus morphine
Trial: 17009531
Drug: Integrated method
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated method (operation + Chinese medicine + dexamethasone + vitamin E)
Trial: 17009531
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine + dexamethasone + vitamin E
Trial: 14643269
Drug: Amiodarone (200mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (200mg orally 3 times a day) plus enalapril (10mg twice a day)
Trial: 7933438
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition including a conventional amino acid solution (control group)
Trial: 7933438
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition including the same amino acid solution supplemented with glycyl-glutamine (GLN group)
Trial: 3119449
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg) in smokers
Trial: 3119449
Drug: Misoprostol (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (800 mcg) in smokers
Trial: 25706948
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg pregabalin orally preoperatively
Trial: 16433711
Drug: NPH-based multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH-based multiple daily insulin injections (MDI)
Trial: 12945134
Drug: Millimetric electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Millimetric electromagnetic radiation (MER) combined therapy
Trial: 12945134
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with 5.6 mm radiation
Trial: 9357123
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin administered twice a day
Trial: 9357123
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (lente insulin)
Trial: 21181026
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose ROM Therapy (rifampin, ofloxacin, minocycline)
Trial: 21181026
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose ROM Therapy
Trial: 18211994
Drug: Ethanol (approximately
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (approximately 80 mg per 100 ml)
Trial: 16940700
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention group consuming an average of 371.4 g/day of Okinawan vegetables for 14 days
Trial: 11173715
Drug: Physical training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical training (8 week program of aerobic exercise at 75% VO(2) peak, 45 min, twice a week and intermittent exercise once a week)
Trial: 9098873
Drug: Understanding of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Understanding of medication directions
Trial: 1490224
Drug: Caffeine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (7 mg kg‐1)
Trial: 21450995
Drug: AS03(A)‐adjuvanted double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03(A)‐adjuvanted double dose (3.75 μg hemagglutinin)
Trial: 21450995
Drug: Nonadjuvanted single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted single dose
Trial: 21450995
Drug: Nonadjuvanted double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted double dose
Trial: 15191200
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential regimen (rabeprazole 20 mg b.i.d. + amoxycillin 1 g b.i.d. for 5 days, followed by rabeprazole 20 mg b.i.d. + clarithromycin 500 mg b.i.d. + tinidazole 500 mg b.i.d. for 5 days)
Trial: 23862170
Drug: 7-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day triple therapy
Trial: 17597398
Drug: 10-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day triple therapy
Trial: 11041467
Drug: Urokinase (UK)
DrugBank: Urokinase (DB00013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urokinase (UK) infusion at 30,000 U/h via each port concurrently, total 250,000 U
Trial: 16569550
Drug: No antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiarrhythmic agent
Trial: 9161237
Drug: Intradermal local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal local anesthetic
Trial: 6421082
Drug: Both preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both preparations (vaginal cream and suppository)
Trial: 30409792
Drug: Paclitaxel (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (80 mg/m2 once per week or 175 mg/m2 every 2 weeks)
Trial: 11851637
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (Evra/Ortho Evra) applied on abdomen
Trial: 11851637
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (Evra/Ortho Evra) applied on buttock
Trial: 11851637
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (Evra/Ortho Evra) applied on torso
Trial: 10335722
Drug: Risedronate 30
RxNorm normalized name: risedronate 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 30 mg daily for 2 months
Trial: 10335722
Drug: Etidronate 400
RxNorm normalized name: etidronate 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate 400 mg daily for 6 months
Trial: 8951188
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg or 200 mg oral doses of nefazodone (NEF) as single doses on Day 1 and multiple (twice daily) doses on Days 12-22.
Trial: 8951188
Drug: Multiple dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dosing of nefazodone (NEF).
Trial: 27025586
Drug: Endocrine Treatment
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine Treatment (ET) alone
Trial: 31786279
Drug: Endocrine Treatment
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine Treatment (ET) + 70 Gy prostatic Radiation Therapy (RT)
Trial: 31786279
Drug: Endocrine Treatment
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine Treatment (ET) with salvage RT
Trial: 26255208
Drug: Nitrofurantoin 100
RxNorm normalized name: nitrofurantoin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin 100 mg, twice daily for 5 days
Trial: 21398094
Drug: Adjunctive SAMe
RxNorm normalized name: SAMe
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive SAMe
Trial: 19404900
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 100 microg daily for 3 days
Trial: 17224471
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor (enalapril 10 mg PO), angiotensin II receptor blocker (losartan 100 mg PO, eprosartan 600 mg PO)
Trial: 28438923
Drug: Reduced-clavulanate A/C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-clavulanate A/C formulation (90 mg amoxicillin/3.2 mg clavulanate/kg/day for 10 days)
Trial: 28438923
Drug: Reduced-clavulanate A/C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-clavulanate A/C formulation (80 mg amoxicillin/2.85 mg clavulanate/kg/day for 10 days)
Trial: 28438923
Drug: Standard A/C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard A/C regimen (90 mg amoxicillin/6.4 mg clavulanate/kg/day)
Trial: 22025143
Drug: Capecitabine (intermittent:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (intermittent: 1,000 mg/m² twice daily for 14 of every 21 days; n = 107)
Trial: 22025143
Drug: Capecitabine (continuous:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (continuous: 650 mg/m² twice daily for 21 of every 21 days; n = 107)
Trial: 22025143
Drug: CMF (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF (oral cyclophosphamide 100 mg/m² days 1 to 14, intravenous methotrexate 40 mg/m² and fluorouracil 600 mg/m² on days 1 and 8 every 28 days; n = 109)
Trial: 15629834
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone (4 mg)
Trial: 11105539
Drug: Flutrimazole 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutrimazole 2% cream (regimen B)
Trial: 11105539
Drug: Flutrimazole 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutrimazole 4% cream (regimen C)
Trial: 11105539
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (regimen D)
Trial: 3890519
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with 10% sulfacetamide sodium ophthalmic solution
Trial: 20975053
Drug: 1.5 μg/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 μg/min human αCGRP infusion
Trial: 11144401
Drug: Cefdinir oral
RxNorm normalized name: cefdinir Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefdinir oral suspension
Trial: 16507381
Drug: Amoxicillin/clavulanate potassium,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate potassium, cefprozil, azithromycin, or generic amoxicillin
Trial: 3698460
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg lorazepam
Trial: 3698460
Drug: 3.0 mg
RxNorm normalized name: TOBRAMYCIN 3.0 mg in 1 mL OPHTHALMIC SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 mg lorazepam
Trial: 29277822
Drug: Bevacizumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (10 mg/kg every 2 weeks) and cyclophosphamide (150-250 mg/m2) added to a combination of gemcitabine, fluorouracil, leucovorin, irinotecan and a platinum analogue.
Trial: 20083352
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection
Trial: 16140397
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine followed by a 23-valent pneumococcal polysaccharide booster
Trial: 12499347
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (ferrous sulfate 60 mg Fe once daily for 8 weeks)
Trial: 27888542
Drug: Non-extended infusion
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-extended infusion (NEI) piperacillin/tazobactam (30-minute infusion)
Trial: 27888542
Drug: Extended infusion
RxNorm normalized name: Extended Infusion Set 6mm Cannula 23" Tubing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended infusion (EI) piperacillin/tazobactam
Trial: 26353825
Drug: VIPP-V (Video-feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VIPP-V (Video-feedback Intervention to promote Positive Parenting) in combination with care-as-usual
Trial: 23531117
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg drospirenone/0.5 mg 17β-estradiol (DRSP/E2)
Trial: 21505096
Drug: C.E.R.A. 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C.E.R.A. 1.2 μg/kg Q4W
Trial: 19767815
Drug: 0% glucose
RxNorm normalized name: Dextrose 10% Oral Solution [SIMILAC 10% GLUCOSE WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0% glucose solution
Trial: 18840313
Drug: 2% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% glucose solution
Trial: 24668608
Drug: 10% glucose
RxNorm normalized name: Dextrose 10% Oral Solution [SIMILAC 10% GLUCOSE WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glucose solution
Trial: 19767815
Drug: Hypertonic carbohydrate-electrolyte
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic carbohydrate-electrolyte solutions
Trial: 18204744
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with standardized grass/rye mix extract
Trial: 305734
Drug: Intramuscular pethidine
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pethidine (30 mg) alone
Trial: 31863561
Drug: Intramyocardial injections
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAEPICARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial injections of autologous bone marrow-derived mesenchymal stromal cells (MSCs)
Trial: 19318667
Drug: Glycopyrrolate (0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (0.005 mg/kg; n = 336)
Trial: 19318667
Drug: Atropine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.01 mg/kg; n = 339)